Brief: Kineta Announces Exclusivity And Right Of First Offer Agreement For Its Vista Blocking Antibody With Tuhura Biosciences
08/07/2024 11:42
July 8 (Reuters) - Kineta Inc KA.O :
* KINETA ANNOUNCES EXCLUSIVITY AND RIGHT OF FIRST OFFER
AGREEMENT
FOR ITS VISTA BLOCKING ANTIBODY WITH TUHURA BIOSCIENCES
* KINETA INC: KINETA WILL RECEIVE A $5 MILLION NONREFUNDABLE
PAYMENT FROM TUHURA
Source text for Eikon: ID:nGNX4N029d
Further company coverage: KA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kineta
See all newsBrief: TuHURA Biosciences And Kineta Stockholders Approve Proposed Merger And All Related Proposals
Brief: Kineta Updates KVA12123 Clinical Results From Ongoing Phase 1/2 Vista101 Study At Society For Immunotherapy Of Cancer
U.S. STOCKS ON THE MOVE-Copper miners, Palo Alto Networks, Lowe's
U.S. STOCKS ON THE MOVE-Lineage, J.B. Hunt, McDonald's
Kineta rises on resuming enrollment in early-stage cancer study